Jan 9, 2026
Three Hits in One Week: The 85% Rule Expands

This is the third major reimbursement change or clarification impacting wound care providers in a single week — and unfortunately, it’s another step in the wrong direction.

They say that events, good or bad, happen in 3s. Well, we have the third thing this week! Is it good or bad? This is the third major change or clarification to patients with wounds this week, and it is basically all bad. It relates to the 85% reduction for NP and PA providers delivering services covered by the physician fee schedule (PFS).

Unfortunately, although separately payable from the application code and involving no “services”, skin substitutes as “incident to” supplies are now also being reduced to 85% of the PFS rate. Yes, they are supplies that have the same cost in the hands of an NP/PA or physician, but it seems that the nearly unique construct that places skin substitutes as both separately payable and covered under the PFS delivers another unintended (or intended) consequence on top of zero wastage, the geographic indexing applied to the $127, and the removal of the LCD which would have at least made Med Advantage plans have to cover these products nationally for DFU and VLUs. An appropriate quote comes to many a mind at this moment:

“Everybody got a plan until they get punched in the face.” (sic)– Mike Tyson.

Except that this is three in one week. On the bright side, HR 6852 is beginning to get some traction among the US House on both sides of the aisle, and this legislation would cure all three problems plus make the application fee rise to $780 from roughly $175 in outpatient settings and raise the PFS rate to between $380-400/cm2. Maybe next we will get some good news for a change.

https://www.congress.gov/bill/119th-congress/house-bill/6852

More News & Updates

Stay Up-To-Date With
Venture Medical

Jan 9, 2026

Learn More About Bill HR 6852

HR 6852 is gaining bipartisan traction in the House. If passed, it would address all three of these issues. This bill aims to restore fair application payments and modernizing the PFS rate structure.

Dec 28, 2025
John Schroeder and Howard Walthall
John Schroeder and Howard Walthall

What? Now the LCDs Are Cancelled?

Dec 15, 2025

2025: A Year of Momentum, Milestones, and Meaningful Impact

We want to take this time to reflect on 2025 and express our gratitude to everyone who was a part of our journey this year.

Dec 15, 2025

Looking Ahead To 2026

Find out what Venture Medical has in store for 2026 and what that means for our community.

Nov 20, 2025
Michael N. Desvigne MD, FACS, CWS, FACCWS
Michael N. Desvigne MD, FACS, CWS, FACCWS

The Crystal Ball: NO ONE HAS IT! A New Chapter in Wound Care From a Plastic Surgeons Perspective

Nov 6, 2025

Venture Medical Issues Statement on CMS 2026 Physician Fee Schedule Final Rule

‍Company reaffirms its commitment to patient access, clinical excellence, and responsible reimbursement reform under the new CMS framework.

Oct 15, 2025

Wound Care Compliance & Audit Defense Essentials: Inside the Series Every Provider Should Be Watching

Venture Medical’s Wound Care Compliance & Audit Defense Essentials webinar series empowers clinicians and administrators to navigate today’s complex regulatory environment with clarity and confidence. Through expert-led sessions covering legal, billing, and investigative insights, the series helps providers stay compliant, reduce audit risk, and strengthen their practice for the future.

Oct 15, 2025
Carey Brandenburg
Carey Brandenburg

Running A Mobile Wound Practice With Confidence

Provider Jessica Hoge, MD shares how she’s streamlined her workflow, improved patient care, and eliminated frustration.

Oct 6, 2025
Howard Walthall
Howard Walthall

Preparing Your Wound Care Practice for January 1st

Sep 11, 2025

Venture Medical's Official Comment On The Physician Fee Schedule

We have asked our industry to make their voices heard and submit their comments to their local and federal legislators regarding the 2026 Proposed Fee Schedule. In this blog post we share our official comment.